Industry Blog

Temporary E-Mail Address

From February 2012, Hanningfield will be operating out of a new factory.

During the next week we will encounter some communication issues as we upgrade our computer server as part of the move. Please use the temporary e-mail address hanningfield@hotmail.co.uk for all e-mail correspondance until 9-February-2012.

New Year, New Factory

From February 2012, Hanningfield will be operating out of a new factory. The new premises is twice the size of our previous factory and is a major step towards helping us offer an improved service for our customers across the globe.

The new address is:

17 Millhead Way
Purdeys Industrial Estate
Rochford
Essex
SS4 1LB
United Kingdom

Tel: +44 (0) 1702 549777
Fax: +44 (0) 1702 549888

Email: info@hanningfield.com
Website: www.hanningfield.com

During the next week we will encounter some communication issues as we upgrade our computer server as part of the move.  Please use the temporary e-mail address hanningfield@hotmail.co.uk for all e-mail correspondance until 9-February-2012.

We look forward to this positive step and to showcasing our new facility to customers over the coming months.

End-of-Year Message

“Firstly, I would like to take this opportunity to thank all those we have worked closely with this year, including our customers, suppliers, employees and many others along the way. This year we have strived to improve every area of the business, to ensure we are able to deliver the quality of solution and machine we pride ourselves upon. During this period of positive change, there are of course some instances where I would need to thank you for your patience and understanding as we look to make such improvements.”

“Generally, 2011 gave us great cause for optimism as sales increased, our team expanded and our equipment was successfully delivered to customers in Europe, North America, South America, Africa and Asia. The global reach of our machinery is a source of great pride for us and offers a rare ‘good news story’ for British engineering. I am pleased to see that the opportunities for next year look better still.”

“Finally, I would like to take this opportunity to formally announce our exciting news as we move to a new production facility from March 2012. The new factory is more than twice the size of our current location and will enable us to better serve our customers in offering the highest quality of product and service. The new facility will also incorporate a dedicated trial area, for testing your materials on our machines. Once we are up and running, I would be pleased to welcome your visit to our new facility.”

“On behalf of everyone at Hanningfield, I would like to wish you a Merry Christmas and a Happy New Year. We  look forward to working with you in 2012.”

Kind regards,

Colin Ellis
Managing Director

Charitable Donation

This year we have chosen to say ‘Merry Christmas’ using this e-mail. Instead of sending out printed cards, we have donated the money to a local charity, St Luke’s Hospice. We feel it is important to support local charities and further to help those which rely upon donations from others.

St Luke’s provide exceptional care to people who wish to see out the rest of their lives in a comfortable and caring environment. The services which are provided by St Luke’s cost them in excess of £3 million per year and we hope to develop our support further in the coming years to help St Luke’s with this.

We all wish you a Merry Christmas at Hanningfield and hope you support our efforts in helping local charities.

Hanningfield exhibit at 2011 ISPE UK Conference

Hanningfield were pleased to participate in this year’s ISPE UK Affiliate Conference in Liverpool, UK, on 24th November 2011.

We would just like to say a quick ‘Thank You’ to everyone who came by and said ‘hello’.

Hanningfield ‘Table-Top’ Stand at 2011 ISPE UK Conference

Following the success of last year, Hanningfield will be exhibitng at the ISPE UK Affiliate Conference in Liverpool, UK, on 24th November 2011.

Last year presented an excellent opportunity to meet with industry professionals and experts, and to discuss many of the current trends affecting pharmaceutical processing.

If you are attending the conference, we would be pleased to meet you.  Just look out for our stand (pictured below).

Hanningfield April/May Bank Holiday Closures

Due to a number of upcoming public holidays in the United Kingdom (Easter and the Royal Wedding), Hanningfield will be open/closed on the following dates:

Thursday-21-April 2011 - Open as usual

Friday-22-April 2011 - Closed

Monday-25-April 2011 - Closed

Tuesday-26-April 2011 - Open as usual

Wednesday-27-April 2011 - Open as usual

Thursday-28-April 2011 - Open as usual

Friday-29-April 2011 - Closed

Monday-2-May 2011 - Closed

Tuesday-3-May 2011 - Open as usual henceforth

As of 3rd May 2011 onwards, Hanningfield will be open as usual for business.

If, in our absence, you have any urgent needs, please contact us at info@hanningfield.com

GMP (Good Manufacturing Practice) Explained

A Technical Article by Colin Ellis (Managing Director, Hanningfield)


What is GMP?

GMP or ‘Good Manufacturing Practice’ is the area of quality assurance which ensures that medicinal (and some food) products are consistently produced and controlled to the quality standards appropriate for their intended use and as required by the product specification. In this respect, GMP is concerned with both quality control and production.

“The FDA inspects manufacturing facilities worldwide using scientifically and cGMP-trained individuals whose job it is to evaluate whether the company is following the cGMP regulations.” GMP regulations are enforceable by law and require that manufacturers, processors, and packagers of pharmaceuticals, medical devices, and some types of food products take proactive steps to ensure that their products are pure, effective and safe to use.

"The FDA ensures cGMP standards are upheld."

GMP regulations address all issues that concern record keeping, hygiene, personnel qualifications, cleanliness, equipment verification and the handling of complaints. These regulations in turn protect the consumer from purchasing a product which is ineffective or potentially life threatening. Failure of manufacturers to comply with GMP regulations can result in very serious consequences such as seizure, recall, fines and ultimately imprisonment.

The main aim of GMP is to consistently produce high quality medicines or medical devices that meet the international standards required for responsibly managed healthcare. Processes used in manufacture are carefully controlled, and any changes to the process must be evaluated. Changes that have an impact on the quality of the finished product are also validated as required and checked for compliance and consistency with the product specifications.

GMP requirements are not definitive instructions on how to manufacture specific products. GMP forms a series of general principles that must be observed during manufacturing. When a company is setting up its quality program and manufacturing process, there may be many ways to comply with GMP requirements. It is the company’s responsibility to determine the most effective and efficient quality process. This provides much flexibility, but also requires that the manufacturer interpret the requirements in a manner which makes sense for each individual business.

GMP is sometimes referred to as ‘cGMP’ or ‘Current GMP’ reminding manufacturers that they must employ technologies and systems which are up to date in order to comply with the relevant regulations. Systems and equipment adopted to prevent contamination and errors in the past may be considered less than adequate by current standards.


The Basic Rules of GMP

• Operators must be adequately trained to carry out and document procedures.

• Instructions and procedures should be written in clear and unambiguous language. These instructions are often referred to as ‘SOP’s’ or ‘Standard Operating Procedures’.

• Records must be kept, (manually or by instrumentation), during manufacture which proves that all the steps required by the defined procedures and instructions were taken and that the quantity and quality of the drug was as expected.

GMP is as much about procedures and operator training, as it is about equipment usage.

"GMP is as much about procedures and operator training, as it is about equipment usage."

• Any deviations from the standard procedure found during the keeping of production records must be investigated and documented.

• Records of manufacture (including distribution) that enable the complete history of a batch to be traced must be kept and retained in a comprehensible and readily accessible form.

• Care must be taken to ensure the distribution of the drugs minimizes any risk to their quality.

• A system must be in place for recalling any batch of drug from sale or supply.

• Complaints about marketed drugs must be examined and the causes of quality defects investigated.

• Appropriate measures must be taken with respect to the recall of defective drugs to prevent any future recurrence.


Equipment Design and Manufacture

GMP also applies to the design and manufacture of process equipment. Although this area of GMP is not strictly covered by legislation, it is the responsibility of the equipment manufacturer to understand the importance of hygienic design and the training of competent staff to design and construct equipment that meets the specific needs of the end user and comply with GMP requirements. Documentation also has to be provided to give evidence of competence and materials used in construction.

GMP also applies to equipment manufacture

"GMP also applies to equipment manufacture"

The following points should be considered in the design and construction of process equipment intended for use in GMP regulated industries;

• Design must avoid where possible ledges, dirt traps and flat surfaces where excess dust layers can build up.

• All equipment should be easy to clean and ideally be dismantled without the use of tools.

• Materials of construction must meet the required specification and evidence of materials used should be available. In some cases thorough traceability may be required through mill certificates or other means of identification.

In general most end users will provide a detailed specification or URS (user requirement specification) which will provide in detail the exact requirements in terms of materials, surface finishes and material certification. Competency of the manufacturers ability is also often required which may include evidence of a recognised quality system and proof of staff competency for areas such as design, welding, electrical and other areas of equipment construction.

Hopefully this has helped to shed some light on GMP. If you have any questions whatsoever, I would be delighted to answer them.


Colin Ellis

About the Author

Colin Ellis is the Managing Director of Hanningfield. He has over 30 years experience in the process industries.

Prior to founding Hanningfield in 1987, Colin worked as an engineer for Smith and Nephew, May and Baker and GlaxoSmithKline.

E-Mail: colin@hanningfield.com

Follow Hanningfield on Twitter

To keep up-to-date with the latest news from Hanningfield you can follow us on Twitter.

To visit our Twitter page, either click here or simply click the icon below.

Containment Q&A

Question and Answer with Colin Ellis (Managing Director, Hanningfield)


As the issue of containment becomes evermore topical, Hanningfield’s Managing Director, Colin Ellis, answers some questions about containment, offering advice, opinion and dispelling a few myths.

 

Q. Firstly, what do you mean by containment?
A.

Containment is the prevention of contamination by means of a barrier. This can mean the contamination of the product, the operator or the environment. Generally people think of containment as stopping contaminants getting out, but it is also equally about stopping contaminants getting in; this is why the barrier is important.

The difficult balance to address is how to create a barrier for containment without affecting ease of operation. It is this problem which challenges manufacturers and equipment suppliers alike.

 

Q. Why has the issue of containment become so pertinent recently?
A.

The issue of containment has always been relevant. However, I think it is fair to say that it has become a particularly hot topic over the past few years - no doubt that ever improving health and safety standards have played a huge part in this. Also manufacturers, particularly in the pharmaceutical industry, are using ever more potent ingredients; the potential dangers associated with these make it is essential that they are properly handled and contained.

It is important to remember that containment is not just a ‘buzzword’, rather it is a method of keeping processes safe and secure.

 

Q. Which industries does containment apply to?
A.

With increasingly strict standards in relation to the exposure of operators to hazardous materials, it means that a broad spectrum of industries, such as pharmaceutical, food, minerals, chemicals and ceramics are all subject to strict legislation for containment.

In fact any industry involved in powder processing or any activity which produces dust should be making every effort to reduce employee exposure to health hazards and explosion risk.

 

Q. What are major benefits of containment?
A.

The importance of powder containment needs to be fully understood to reduce operational injuries and industrial claims, as well as improving general hygiene standards and issues affecting the welfare of employees. Although welfare is a major factor in controlling exposure to hazards other benefits are reduced waste, less likelihood of a dust explosion and an improved working environment.

 

Q. Are there any simple ways to comply with containment?
A.

Most dust or excess powder material is created during transfer or transportation within the process area. Processes such scooping, pouring and tipping all create dust problems. If these actions are eliminated or controlled the problem is easily solved.

The most cost effective containment solution is to use silicone sleeves and seals for containing dust during transfer processes. Scooping, tipping or pouring can all be replaced by using vacuum transfer systems which keeps material contained during any transfer process.

 

Q. Is containment a wise investment?
A.

Despite the inevitable costs associated with improving containment, the financial investment can be soon recaptured through improved efficiency. Reduction in waste by keeping products where they should be and in the case of vacuum conveying reduced manpower are obvious areas of a definite return on investment.

Improved safety also has an impact on productivity, which provides the additional benefit of an improved employee/employer relationship. To sum up it is quite clear that apart from certain legal requirements to ensure adequate operator safety there are potential longer term savings to be made in improving efficiency through a carefully planned contained process design.

 

To learn more about Hanningfield’s containment solutions, please click the link below:


Colin Ellis

About the Author

Colin Ellis is the Managing Director of Hanningfield. He has over 30 years experience in the process industries.

Prior to founding Hanningfield in 1987, Colin worked as an engineer for Smith and Nephew, May and Baker and GlaxoSmithKline.

E-Mail: colin@hanningfield.com

Tag Cloud